Back
Green River Gold Vs. Kymera Therapeutics Industry Stock Comparison
Sell
11
CCR.CX
Green River Gold
Last Price:
0.0200
Seasonality Move:
-11.65%
Buy
71
KYMR
Kymera Therapeutics
Last Price:
46.19
Seasonality Move:
65.72%
Sell
11
Green River Gold (CCR.CX)
is a Sell
Is Green River Gold a Buy, Sell or Hold?
- The current Green River Gold [CCR.CX] share price is $0.0200. The Score for CCR.CX is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- CCR.CX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
71
Kymera Therapeutics (KYMR)
is a Buy
Is Kymera Therapeutics a Buy, Sell or Hold?
- The current Kymera Therapeutics [KYMR] share price is $49.02. The Score for KYMR is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
- KYMR is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CCR.CX Stock Price Chart
What is Green River Gold's stock price today?
-
The Green River Gold share price today is $0.0200
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CCR.CX is experiencing selling pressure, which indicates risk of future bearish movement.
KYMR Stock Price Chart
What is Kymera Therapeutics's stock price today?
-
The Kymera Therapeutics share price today is $49.02
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KYMR is experiencing buying pressure, which is a positive indicator for future bullish movement.
CCR.CX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0 | Sell |
Relative Strength Index (14 RSI): | 41.04 | Sell |
Chaikin Money Flow: | -20000 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.0236 - 0.0236) | Sell |
Bollinger Bands (100): | (0.0208 - 0.0408) | Sell |
KYMR Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 59.12 | Buy |
Chaikin Money Flow: | 317205 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (43.81 - 49.49) | Buy |
Bollinger Bands (100): | (34.86 - 47.92) | Buy |
CCR.CX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.02 | Sell |
20-day SMA: | 0.02 | Sell |
50-day SMA: | 0.03 | Sell |
200-day SMA: | 0.04 | Sell |
8-day EMA: | 0.02 | Sell |
20-day EMA: | 0.02 | Sell |
50-day EMA: | 0.03 | Sell |
200-day EMA: | 0.04 | Sell |
KYMR Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 44.58 | Buy |
20-day SMA: | 46.67 | Buy |
50-day SMA: | 46.11 | Buy |
200-day SMA: | 38.62 | Buy |
8-day EMA: | 45.67 | Buy |
20-day EMA: | 45.85 | Buy |
50-day EMA: | 45.2 | Buy |
200-day EMA: | 38.5 | Buy |
Green River Gold Earnings Growth & CCR.CX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Kymera Therapeutics Earnings Growth & KYMR Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.23 per share, and a decrease next year of $0.47 per share.
Green River Gold Technical Analysis
Oct 2 | Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
02 | 03 | 04 | 07 | 08 | 09 | 10 | 11 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Kymera Therapeutics Technical Analysis
Oct 3 | Oct 4 | Oct 7 | Oct 8 | Oct 9 | Oct 10 | Oct 11 | Oct 14 | Oct 15 | Oct 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | ||||||||||
03 | 04 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |